SCHEMBL7220879

SCHEMBL7220879

CCc1cccc2c(Br)cc(C(F)(F)F)nc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
GABRA1 P14867 2/20 0.38
GABRB2 P47870 2/20 0.38
KCNH2 Q12809 4/20 0.37
ELANE P08246 1/20 0.37
CYP2D6 P10635 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
ENPP3 O14638 1/20 0.35
ENPP1 P22413 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7219919 0.82 GABRA1 (0.42) MEN1KMT2AGABRA1GABRB2KCNH2
SCHEMBL2790491 0.81 KCNH2 (0.46) KCNH2CYP2D6KDM4EALDH1A1CYP1A2
SCHEMBL6806506 0.80 ELANE (0.47) MEN1KMT2AELANEKDM4EALDH1A1
SCHEMBL11836535 0.77 NT5E (0.46) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL7235527 0.77 TNKS (0.44) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL18015835 0.76 GABRA1 (0.39) MEN1KMT2AGABRA1GABRB2PTGS2
SCHEMBL10175205 0.76 CYP2D6 (0.50) MEN1KMT2AKCNH2CYP2D6KDM4E
SCHEMBL6918746 0.75 ALDH1A1 (0.41) KCNH2CYP2D6KDM4EALDH1A1CYP1A2
SCHEMBL7234880 0.74 ADORA2A (0.63) MEN1KMT2AKCNH2CYP2D6KDM4E
SCHEMBL9829082 0.71 PDE4B (0.42) MEN1KMT2AKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583156-B1 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol VERNALIS RESEARCH LIMITED (GB) 2003-06-24 US disclosed
EP-1107760-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2001-06-20 EP disclosed
WO-2000013681-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2000-03-16 WO disclosed